173 related articles for article (PubMed ID: 21592704)
1. Should breast MRI be performed with adjustment for the phase in patients' menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients' menstrual cycle.
Uematsu T; Kasami M; Watanabe J
Eur J Radiol; 2012 Jul; 81(7):1539-42. PubMed ID: 21592704
[TBL] [Abstract][Full Text] [Related]
2. Background enhancement of mammary glandular tissue on breast dynamic MRI: imaging features and effect on assessment of breast cancer extent.
Uematsu T; Kasami M; Watanabe J
Breast Cancer; 2012 Jul; 19(3):259-65. PubMed ID: 21618028
[TBL] [Abstract][Full Text] [Related]
3. Does MRI breast "density" (degree of background enhancement) correlate with mammographic breast density?
Hansen NL; Kuhl CK; Barabasch A; Strobel K; Schrading S
J Magn Reson Imaging; 2014 Aug; 40(2):483-9. PubMed ID: 24446230
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of quantitative analysis of background enhancement on breast MR images: association with menstrual cycle and mammographic breast density.
Scaranelo AM; Carrillo MC; Fleming R; Jacks LM; Kulkarni SR; Crystal P
Radiology; 2013 Jun; 267(3):692-700. PubMed ID: 23418005
[TBL] [Abstract][Full Text] [Related]
5. Background enhancement in breast MR: correlation with breast density in mammography and background echotexture in ultrasound.
Ko ES; Lee BH; Choi HY; Kim RB; Noh WC
Eur J Radiol; 2011 Dec; 80(3):719-23. PubMed ID: 20709479
[TBL] [Abstract][Full Text] [Related]
6. Background parenchymal enhancement on breast MRI: influence of menstrual cycle and breast composition.
Kang SS; Ko EY; Han BK; Shin JH; Hahn SY; Ko ES
J Magn Reson Imaging; 2014 Mar; 39(3):526-34. PubMed ID: 23633296
[TBL] [Abstract][Full Text] [Related]
7. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue.
Delille JP; Slanetz PJ; Yeh ED; Kopans DB; Garrido L
Breast J; 2005; 11(4):236-41. PubMed ID: 15982388
[TBL] [Abstract][Full Text] [Related]
8. Mammographic density changes during the menstrual cycle.
Ursin G; Parisky YR; Pike MC; Spicer DV
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):141-2. PubMed ID: 11219771
[TBL] [Abstract][Full Text] [Related]
9. High cancer yield and positive predictive value: outcomes at a center routinely using preoperative breast MRI for staging.
Gutierrez RL; DeMartini WB; Silbergeld JJ; Eby PR; Peacock S; Javid SH; Lehman CD
AJR Am J Roentgenol; 2011 Jan; 196(1):W93-9. PubMed ID: 21178040
[TBL] [Abstract][Full Text] [Related]
10. Use of dynamic phase subtraction (DPS) map in dynamic contrast-enhanced MRI of the breast.
Ogura A; Hayakawa K; Yoshida S; Maeda F; Saeki F; Syukutani A
J Comput Assist Tomogr; 2011; 35(6):749-52. PubMed ID: 22082548
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women.
Wright H; Listinsky J; Rim A; Chellman-Jeffers M; Patrick R; Rybicki L; Kim J; Crowe J
Am J Surg; 2005 Oct; 190(4):572-5. PubMed ID: 16164923
[TBL] [Abstract][Full Text] [Related]
12. Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.
Koo HR; Moon WK; Chun IK; Eo JS; Jeyanth JX; Chang JM; Cho N; Kang KW
Eur J Radiol; 2013 Oct; 82(10):1738-42. PubMed ID: 23806533
[TBL] [Abstract][Full Text] [Related]
13. [MR-imaging of the breast at 0.5 Tesla: menstrual-cycle dependency of parenchymal contrast enhancement in healthy volunteers with oral contraceptive use?].
Lorenzen J; Welger J; Lisboa BW; Krupski G; Adam G
Rofo; 2003 Apr; 175(4):502-6. PubMed ID: 12677505
[TBL] [Abstract][Full Text] [Related]
14. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
Hambly NM; Liberman L; Dershaw DD; Brennan S; Morris EA
AJR Am J Roentgenol; 2011 Jan; 196(1):218-24. PubMed ID: 21178070
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of variability in mammographic density during the menstrual cycle.
Morrow M; Chatterton RT; Rademaker AW; Hou N; Jordan VC; Hendrick RE; Khan SA
Breast Cancer Res Treat; 2010 Jun; 121(3):565-74. PubMed ID: 19669673
[TBL] [Abstract][Full Text] [Related]
16. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
[TBL] [Abstract][Full Text] [Related]
17. Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast.
Biglia N; Bounous VE; Martincich L; Panuccio E; Liberale V; Ottino L; Ponzone R; Sismondi P
Eur J Surg Oncol; 2011 Mar; 37(3):199-204. PubMed ID: 21237612
[TBL] [Abstract][Full Text] [Related]
18. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
Gokalp G; Topal U; Yildirim N; Tolunay S
Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
[TBL] [Abstract][Full Text] [Related]
19. Prenatal and perinatal correlates of adult mammographic breast density.
Cerhan JR; Sellers TA; Janney CA; Pankratz VS; Brandt KR; Vachon CM
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1502-8. PubMed ID: 15941963
[TBL] [Abstract][Full Text] [Related]
20. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy.
Baltzer PA; Dietzel M; Vag T; Burmeister H; Gajda M; Camara O; Pfleiderer SO; Kaiser WA
Rofo; 2011 May; 183(5):441-7. PubMed ID: 21318935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
